Dynamic Uric Acid Changes and Outcomes in CKD in the African American Study of Kidney Disease and Hypertension

2025/10/11 by Priyadarshini John, Diana Jalal · 1 voice
Medicine · #Alcohol Consumption and Health Effects #Gout, Hyperuricemia, Uric Acid #Liver Disease and Transplantation

paper · doi:10.1016/j.ekir.2025.09.051

openalex publication_date 2025/10/11 · openalex created_date 2025/10/11 · crossref created 2025/10/11 · crossref issued 2025/12/01 · crossref published 2025/12/01 · crossref published-print 2025/12/01 · crossref deposited 2025/12/20 · crossref indexed 2025/12/20 · openalex updated_date 2026/07/23

Citations

• Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy
• Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

Discussions

• Dynamic #Uric Acid Changes and Outcomes in #CKD in the African American Study of Kidney Disease and Hypertension https://doi.org/10.1016/j.ekir.2025.09.051 Original Article: https://doi.org/10.1016 [bsky, 2 points, 0 comments]